Angiogenesis in Pulmonary Fibrosis

Slides:



Advertisements
Similar presentations
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Relationship Between Vascular Endothelial Growth.
Advertisements

CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Christine.
Volume 32, Issue 1, Pages (July 1957)
Volume 120, Issue 1, Pages S66-S68 (July 2001)
Colloquium on Therapy of Right Heart Failure
Volume 102, Issue 4, Pages (October 1992)
Volume 114, Issue 6, Pages (December 1998)
Volume 46, Issue 5, Pages (November 1964)
Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke
Prophylactic Irradiation of the Lung in Ewing's Sarcoma
Angiogenic switch and progression during tumor development
Volume 91, Issue 1, Pages (January 1987)
Volume 116, Issue 5, Pages (November 1999)
Right-Sided Chest Pain with Progressive Dyspnea
Wound repair in healthy lungs and IPF
Volume 56, Issue 1, Pages (July 1969)
Epidemiology and Treatment of Lung Cancer in Seattle
Bovine Tuberculosis Eradication
Jack Needle Lung Biopsy in Pneumoconiosis
Cystic Disease of the Lung with Acquired Systemic Pulmonary Shunt
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Paul Wolf, M.D., Christopher Hall, M.D., J.P. Kilbourn, Ph.D.  CHEST 
Air Pollution and Chest Disease
Epidemiologic Studies of Air Pollution*
Angiogenesis in Chronic Lung Disease
A Solitary Pulmonary Mass in Multiple Myeloma*
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Valve Drainage of the Pleural Cavity
Apical Localization of Pulmonary Tuberculosis, Chronic Pulmonary Histoplasmosis, and Progressive Massive Fibrosis of the Lung  Robert A Goodwin, M.D.,
Volume 108, Issue 1, Pages (July 1995)
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Wound repair in healthy lungs and IPF
CD5: A New Partner for IL-6
Tipping the balance from angiogenesis to fibrosis in CKD
Volume 145, Issue 3, Pages (March 2014)
Intralobar Bronchopulmonary Sequestration of the Lung
Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis  Seyit Temel.
Volume 79, Issue 2, Pages (February 1981)
Fibromyxoma of Pleura: Report of Case
Multifocal Idiopathic Fibromatosis
Counterpoint: Should All ICU Patients Receive Continuous Sedation? No
Volume 146, Issue 5, Pages (May 2014)
Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer: Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival  Tom Donnem,
Cystic Disease of the Lung with Acquired Systemic Pulmonary Shunt
Fibrotic Stage of Allergic Bronchopulmonary Candidiasis
Possible Role of Statins in COPD-Related Pulmonary Hypertension
Unusual Diffuse Pulmonary Lymphatic Proliferation in a Young Boy
Unusual Coin Lesion in the Lung
Does OSA Upregulate Cardioprotective Pathways to an Ischemic Insult?
Rahi Victory, M. D. , F. R. C. S. C. , Ghassan M. Saed, Ph. D
Volume 155, Issue 2, Pages (February 2019)
Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy 
A 57-Year-Old Man With Subacute Progressive Hemoptysis and Fevers
Kristy Red-Horse, Yongping Crawford, Farbod Shojaei, Napoleone Ferrara 
Volume 92, Issue 1, Pages (July 1987)
Volume 72, Issue 2, Pages (July 2007)
Recognizing Pulmonary Torsion
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Pulmonary Manifestations in a Case of Multiple Myeloma
Jair Bar, MD, PhD, Glenwood D. Goss, MD, FCPSA, FRCPC 
A Breath of Fresh Air in Lung Regeneration
Volume 42, Issue 2, Pages (August 1962)
Calcification of the Coronary Artery
Volume 72, Issue 5, Pages (November 1977)
COUNTERPOINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? No 
High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine 
Platelets arrive at the scene of fibrosis……studies
Pleural Effusion and Renal Cell Carcinoma
New Members of the Editorial Board
Presentation transcript:

Angiogenesis in Pulmonary Fibrosis Chandru Hanumegowda, PhD, Laszlo Farkas, MD, Martin Kolb, MD, PhD  CHEST  Volume 142, Issue 1, Pages 200-207 (July 2012) DOI: 10.1378/chest.11-1962 Copyright © 2012 The American College of Chest Physicians Terms and Conditions

Figure 1 The concept of angiogenesis in pulmonary fibrosis. There is reduced small vessel density in fibroblastic foci (FF) and dense scar tissue in some areas of the fibrotic lung, whereas the sections between normal and fibrotic tissue contain more microvascular structures. Dilated larger vessels and bronchopulmonary anastomoses are found in areas with honeycombing and bronchiectasis. The local microenvironment has a major influence not only on fibrogenesis but also on vessel homeostasis and angiogenesis. For example, angiogenic factors such as VEGF and FGF, which also have profibrotic properties, are decreased in FF but increased in the surrounding tissue, similar to angiogenic ELR+ CXC chemokines. In contrast, the expression of angiostatic elements (eg, PEDF and endostatin) is high in FF and low in the surroundings. The density of microvessels is overall reduced in fibrotic lungs, thus contributing to the development of pulmonary hypertension. AEC = alveolar epithelial cell; ELR = three-amino-acid sequence (glutamic acid-leucine-arginine); FGF = fibroblast growth factor; PEDF = pigment epithelium-derived factor; VEGF = vascular endothelial growth factor. CHEST 2012 142, 200-207DOI: (10.1378/chest.11-1962) Copyright © 2012 The American College of Chest Physicians Terms and Conditions

Figure 2 Fibrosis, angiogenesis/vessel density and growth factors are closely interrelated inidiopathic pulmonary fibrosis (IPF). Two major scenarios are plausible: (1) fibrosis causes impaired angiogenesis through growth factor abnormalities and thereby vessel loss in some areas of the lung but increased vessel density in others, possibly as a mechanism to control fibrogenic signals, with the net effect being reduced vascular surface area and development of pulmonary hypertension. (2) Impaired angiogenic signals and vessel density cause abnormal tissue repair and thereby promote fibrosis progression. It is yet unclear if the abnormal vasculature found in IPF lungs is cause or consequence of the disease, or, in keeping with the illustration, which one of the wheels turns first. ++ = increase of fibrosis and growth factor activity; −− = decrease in vessel density. CHEST 2012 142, 200-207DOI: (10.1378/chest.11-1962) Copyright © 2012 The American College of Chest Physicians Terms and Conditions